PMID- 34419855 OWN - NLM STAT- MEDLINE DCOM- 20220126 LR - 20220126 IS - 1532-8198 (Electronic) IS - 1092-9134 (Linking) VI - 54 DP - 2021 Oct TI - The role of alpha-smooth muscle actin in confirming the microinvasion of laryngeal squamous cell carcinoma. PG - 151804 LID - S1092-9134(21)00104-0 [pii] LID - 10.1016/j.anndiagpath.2021.151804 [doi] AB - BACKGROUND: The diagnosis of microinvasive laryngeal squamous cell carcinoma (LSCC) is not always straightforward and sometimes can be very challenge in daily clinical practice. The focus lies in the confirmation of microinvasion. Cancer-associated fibroblasts (CAFs), as the major element of reactive tumor stroma, are believed to participate actively in the growth and invasion of tumor cells. OBJECTIVES: To evaluate the diagnostic role of alpha-smooth muscle actin (alpha-SMA) labelling CAFs in microinvasive LSCC. METHODS: A total of 81 laryngeal biopsy specimens were retrieved, including 41 cases of microinvasive LSCC with depth of invasion no more than 3 mm, 20 laryngeal squamous intraepithelial lesion (SIL), and 20 benign pseudoepitheliomatous hyperplasia (PEH). All cases were stained for immunohistochemistry, using antibody against the alpha-SMA antigen. The correlation between the presence of CAFs in microinvasive LSCC and tumor histological characteristics was investigated. RESULTS: Immunoreactivity of alpha-SMA was detected in twenty-nine microinvasive LSCC (29/41, 71%), while no reactivity was observed in laryngeal SIL (0/20, 0%), and rarely in PEH (2/20, 10%). The alpha-SMA expression pattern in stroma of microinvasive LSCC was significantly different from that of SIL (chi(2) = 26.966, p = 0.000) and PEH (chi(2) = 19.838, p = 0.000). In addition, there seemed to be a certain correlation between the histological characteristics of microinvasive LSCC and the presence of interstitial CAFs. CONCLUSIONS: This study highlights the practical role of utilizing alpha-SMA in the pathological diagnosis of microinvasive LSCC, with emphasis on variable histomorphologic features of microinvasive LSCC. CI - Copyright (c) 2021. Published by Elsevier Inc. FAU - Bai, Yuping AU - Bai Y AD - Department of Pathology, Beijing Tongren Hospital, Capital Medical University, Beijing Key Laboratory of Head and Neck Molecular Diagnostic Pathology, Beijing 100730, China. FAU - Yue, Changli AU - Yue C AD - Department of Pathology, Beijing Tongren Hospital, Capital Medical University, Beijing Key Laboratory of Head and Neck Molecular Diagnostic Pathology, Beijing 100730, China. FAU - Lu, Zhichun AU - Lu Z AD - Department of Pathology and Laboratory Medicine, Boston Medical Center/Boston University School of Medicine, Boston, MA, United States. FAU - Li, Pingdong AU - Li P AD - Department of Otorhinolaryngology, Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China. FAU - Liu, Honggang AU - Liu H AD - Department of Pathology, Beijing Tongren Hospital, Capital Medical University, Beijing Key Laboratory of Head and Neck Molecular Diagnostic Pathology, Beijing 100730, China. Electronic address: liuhg1125@163.com. LA - eng PT - Journal Article DEP - 20210804 PL - United States TA - Ann Diagn Pathol JT - Annals of diagnostic pathology JID - 9800503 RN - 0 (Actins) RN - 0 (Biomarkers, Tumor) SB - IM MH - Actins/metabolism MH - Adult MH - Aged MH - Aged, 80 and over MH - Biomarkers, Tumor/metabolism MH - Carcinoma, Squamous Cell/diagnosis/*pathology MH - Female MH - Head and Neck Neoplasms/diagnosis/*pathology MH - Humans MH - Immunohistochemistry/methods MH - Laryngeal Neoplasms/diagnosis/*pathology MH - Male MH - Middle Aged MH - Muscle, Smooth/metabolism/*pathology MH - Squamous Cell Carcinoma of Head and Neck/metabolism/pathology OTO - NOTNLM OT - Cancer-associated fibroblasts OT - Histomorphologic feature OT - Microinvasive laryngeal squamous cell carcinoma OT - Pathological diagnosis OT - alpha-Smooth muscle actin EDAT- 2021/08/23 06:00 MHDA- 2022/01/27 06:00 CRDT- 2021/08/22 20:58 PHST- 2021/05/14 00:00 [received] PHST- 2021/07/06 00:00 [revised] PHST- 2021/07/25 00:00 [accepted] PHST- 2021/08/23 06:00 [pubmed] PHST- 2022/01/27 06:00 [medline] PHST- 2021/08/22 20:58 [entrez] AID - S1092-9134(21)00104-0 [pii] AID - 10.1016/j.anndiagpath.2021.151804 [doi] PST - ppublish SO - Ann Diagn Pathol. 2021 Oct;54:151804. doi: 10.1016/j.anndiagpath.2021.151804. Epub 2021 Aug 4.